Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
---|
01/17/2013 | WO2013007959A1 Novel imaging agents, process for the preparation thereof and pharmaceutical compositions containing same |
01/17/2013 | WO2013007159A1 N-dual heteronuclear carbazolyl oxime ester compound |
01/17/2013 | US20130018159 Copolymerizable methine and anthraquinone compounds and articles containing them |
01/17/2013 | US20130018073 Indole derivative |
01/17/2013 | US20130018067 Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (fprl-1) receptor modulators |
01/17/2013 | US20130018026 Halogenated phenols for diagnostics, antioxidant protection and drug delivery |
01/17/2013 | CA2841983A1 Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (fprl-1) receptor modulators |
01/16/2013 | EP2546233A1 Hydrobenzamide derivatives as inhibitors of HSP90 |
01/16/2013 | EP2546232A1 Diphenyl Substituted Alkanes |
01/16/2013 | CN102884046A Method for separating off tryptophan |
01/16/2013 | CN102875601A Preparation method and application for phosphine-oxazoline ligand, and ionic metal complex, enantiomer or racemate thereof |
01/16/2013 | CN102875448A Synthetic method for preparing indole spiral cyclopentane derivant |
01/16/2013 | CN102875447A Method for preparing 2,7-dibromocarbazole |
01/16/2013 | CN102875446A Preparation method of N-alkyl-4-amino-phthalimide |
01/16/2013 | CN102875445A Synthetic method of 5-trifluoromethyl isatin |
01/16/2013 | CN102875444A Synthetic method of oxidation indoles compound |
01/16/2013 | CN102875443A Method for extracting abrine |
01/16/2013 | CN102875442A Preparation method of high-purity hypaphorine |
01/16/2013 | CN102875441A Plexxikon inc |
01/16/2013 | CN102875440A Preparation method of 3-(4-chlorobutyl)-5-cyanoindole |
01/16/2013 | CN102875276A Method for preparing cyan aromatic hydrocarbon by using aryl bromide |
01/16/2013 | CN102875275A Method for preparing aryl nitrile by aryl halogenide |
01/16/2013 | CN102875270A Method for synthesizing trifluoromethyl amine |
01/16/2013 | CN102872914A Chiral double-oxazoline amino metal catalyst, as well as preparation method and application thereof |
01/16/2013 | CN102190612B Endophytic fungus diterpene alkaloid compound of natural seaweed as well as preparation method and application thereof |
01/16/2013 | CN101910128B Novel diazeniumdiolate derivatives, method for the preparation thereof and pharmaceutical compositions containing the same |
01/16/2013 | CN101878027B Multitarget compounds active at a PPAR and cannabinoid receptor |
01/16/2013 | CN101831289B Pyrene and fluorene copolymerized blue light materials with space structures |
01/16/2013 | CN101508649B Novel organic electroluminescent compounds and organic electroluminescent device using the same |
01/15/2013 | US8354668 Emissive triaryls |
01/15/2013 | US8354443 Cyclopropane indolinone derivatives |
01/15/2013 | US8354440 3-3-di-substituted-oxindoles as inhibitors of translation initiation |
01/10/2013 | WO2013005157A1 Sulfone derivatives and their use as pkm2 modulators for the treatment of cancer |
01/10/2013 | WO2013004290A1 Cyclic amine derivatives as ep4 receptor antagonists |
01/10/2013 | US20130012724 New biologically active compound n-[3-(4-nitrophenylamino)-indole-2-ilmethylene]aminoguanidine hydrochloride with anti-inflammatory activity |
01/10/2013 | US20130012723 Methods and compounds for producing dipeptidyl peptidase iv inhibitors and intermediates thereof |
01/10/2013 | US20130012705 Dicycloazaalkane derivatives, preparation processes and medical uses thereof |
01/10/2013 | US20130012702 Purification of progesterone receptor modulators |
01/10/2013 | US20130012548 Deuterium-substituted omega-diphenylurea and derivatives thereof and pharmaceutical compositions comprising the compounds |
01/10/2013 | US20130012536 Modulators of atp-binding cassette transporters |
01/10/2013 | US20130011538 Crystal of multivalent metal salt of monatin |
01/10/2013 | US20130009142 Charge transport compositions and electronic devices made with such compositions |
01/10/2013 | CA2839116A1 Cyclic amine derivatives as ep4 receptor antagonists |
01/09/2013 | EP2542525A1 Cationic 6-aminoindolines, dyeing compositions containing them, processes and uses thereof |
01/09/2013 | EP2542238A1 Compounds for immunoproteasome inhibition |
01/09/2013 | EP2542086A1 Compounds and therapeutic uses thereof |
01/09/2013 | CN102863437A Preparation method of lurasidone |
01/09/2013 | CN102863373A Method for synthesizing 5-benzylazaspiro[2,4]heptane |
01/09/2013 | CN102863372A Synthetic method of deoxyribonucleic acid (DNA) methyl transferase inhibitor |
01/09/2013 | CN102863350A Anti-inflammatory analgesia mutual prodrug of non-steroidal antiinflammatory drug and preparation method thereof |
01/09/2013 | CN101421238B Method for producing polycyclic proline derivative or acid addition salt thereof |
01/08/2013 | US8350054 Optical filter |
01/08/2013 | US8350047 Methods of preparing secondary carbinamine compounds with boronic acids |
01/08/2013 | US8349885 Indole and indazole derivatives having a cell-, tissue- and organ-preserving effect |
01/08/2013 | US8349548 Oxime ester photoinitiators |
01/08/2013 | CA2642668C Indole-3-carboxylic acid amide and ester compounds bearing phenyl groups having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
01/08/2013 | CA2562571C Novel androgens |
01/08/2013 | CA2548020C Method for producing (3-oxo-2,3-dihydro-1h-isoindol-1-yl)acetylguanidine derivatives |
01/08/2013 | CA2545452C Ortho-substituted pentafluoride sulfanyl-benzenes, method for the production thereof and the use thereof in the form of valuable synthesis intermediate stages |
01/08/2013 | CA2526530C (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent |
01/08/2013 | CA2486838C Organic amine salts of glutamic acid derivatives and their application |
01/08/2013 | CA2478731C Carbamates as hiv protease inhibitors |
01/03/2013 | WO2013001499A1 Indoleamine derivatives for the treatment of central nervous system diseases |
01/03/2013 | WO2013000651A1 Fluorinated arylalkylaminocarboxamide derivatives |
01/03/2013 | WO2013000395A1 Novel histone deacetylase inhibitor of benzamides and use thereof |
01/03/2013 | WO2012150784A3 Novel indole derivative or pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic diseases containing same as active ingredient |
01/03/2013 | US20130001540 Compound including indole derivative in which two tertiary amines are substituted, organic electronic element using same, and terminal thereof |
01/03/2013 | US20130001524 Heterocyclic compound and organic light-emitting device comprising the same |
01/03/2013 | US20130001521 Application of triphenylene derivatives in organic electroluminescent devices |
01/03/2013 | US20130001476 Polymers of 8,9-dihydrobenzo[def]carbazole and their use as organic semiconductors |
01/03/2013 | CA2838314A1 Indoleamine derivatives for the treatment of central nervous system diseases |
01/03/2013 | CA2833824A1 Fluorinated arylalkylaminocarboxamide derivatives |
01/02/2013 | EP2541635A1 Organic electroluminescent element |
01/02/2013 | EP2540715A1 Fused substituted aminopyrrolidine derivative |
01/02/2013 | EP2540706A2 Process for preparing indol-5-oxy-quinazoline derivatives and intermediates |
01/02/2013 | EP2540705A2 Process for preparing indol-5-oxy-quinazoline derivatives and intermediates |
01/02/2013 | EP2539322A1 Inhibitors of beta-secretase |
01/02/2013 | EP2539321A1 Saxagliptin intermediates, saxagliptin polymorphs, and processes for preparation thereof |
01/02/2013 | EP2539320A1 A process for the preparation of substituted prolyl peptides and similar peptidomimetics |
01/02/2013 | EP2539316A1 Latent acids and their use |
01/02/2013 | CN102858763A Prolylhydroxylase inhibitors and methods of use |
01/02/2013 | CN102858743A Spiro-condensed cyclohexane derivatives as HSL inhibitors useful for the treatment of diabetes |
01/02/2013 | CN102858742A Trpv1 vanilloid receptor antagonists with a bicyclic portion |
01/02/2013 | CN102858741A Novel methods for the preparation of P2X7R antagonists |
01/02/2013 | CN102850259A Preparation method for 6-halogen substituted-1,2,3,4-terahydrocarbazole intermediate of anti-hepatitis c drugs |
01/02/2013 | CN102850258A Preparation method of OLED (organic light-emitting diode) material intermediate 6-methyl-1,2,3,4-tetrahydrocarbazole |
01/02/2013 | CN102850257A Preparation method of 1,2-cyclopentane dicarboximide |
01/02/2013 | CN102850256A Method for preparing tryptophan nitrate |
01/02/2013 | CN102850255A Preparation method of 5-alkyl-2,3-diphenylindole |
01/02/2013 | CN102850254A UV-curable monomer and its preparation method, polymerizable composition and backlight module |
01/02/2013 | CN102850236A Novel benzamide histone deacetylase inhibitor and application thereof |
01/02/2013 | CN102850177A Application of triphenylene derivatives in organic electroluminescent devices |
01/02/2013 | CN102850153A Asymmetric reduction reaction method for catalyzing alpha, beta-unsaturated ketene and saturated ketene |
01/02/2013 | CN102127422B Carbazole derivative, and light emitting element material, light emitting element, and electronic appliance obtained using the same |
01/02/2013 | CN102070459B Method for preparing amino-compound through catalytic reduction of nitro-compound |
01/02/2013 | CN102060747B Phenyl spirane ketone enol ester compound and application thereof |
01/02/2013 | CN101747321B Indole-3-benzylamine derivative, preparation method and application |
01/02/2013 | CN101573034B Process for the synthesis of (+) and (-) -1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane |
01/02/2013 | CN101516856B Heterocyclic bridged biphenyls and their use in oleds |
01/02/2013 | CN101014569B Oxime ester initiators |